CDMOs: The Good, The Great And The Exceptional (And How To Tell The Difference)

Outsourcing to a contract development and manufacturing organization (CDMO) can be critical to ensuring success for many early stage cell and gene therapy (CGT) companies with limited resources, but finding the right partner can often seem daunting in an increasingly crowded field.

When evaluating CDMOs, it’s important to look beyond the basic attributes to the unique capabilities that will serve your organization best. And since outsourcing decisions are driven primarily by gaining access to specialized equipment and expertise without major capital investment, these are the factors to pay particular attention to when parsing CDMO claims.